SCHEMBL6036076

SCHEMBL6036076

CN(CCCCC(=O)c1ccc2c(c1)N(C)S(O)(O)N2C)CCc1ccccc1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.37
MCHR1 Q99705 2/20 0.36
ACHE P22303 4/20 0.36
BCHE P06276 2/20 0.36
AOC3 Q16853 1/20 0.36
THRA P10827 1/20 0.34
THRB P10828 1/20 0.34
NR1I2 O75469 1/20 0.34
ADRB2 P07550 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
CHRM1 P11229 1/20 0.34
DRD2 P14416 1/20 0.34
ADRA2B P18089 1/20 0.34
ADRA2C P18825 1/20 0.34
CHRM3 P20309 1/20 0.34
CNR1 P21554 1/20 0.34
SLC6A2 P23975 1/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
SLC6A4 P31645 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4880703 0.99 TAAR1 (0.36) TAAR1MCHR1ACHEBCHEAOC3
SCHEMBL6036074 0.92 TAAR1 (0.37) TAAR1MCHR1ACHEBCHEAOC3
Hydrochloric Acid SCHEMBL4880698 0.91 TAAR1 (0.36) TAAR1MCHR1ACHEBCHEAOC3
SCHEMBL4887165 0.89 TAAR1 (0.33) TAAR1MCHR1ACHEBCHEAOC3
Hydrochloric Acid SCHEMBL4891123 0.87 MCHR1 (0.37) TAAR1MCHR1ACHEBCHEAOC3
SCHEMBL6035240 0.87 BCHE (0.44) ACHEBCHEAOC3CHRM1SIGMAR1
Hydrochloric Acid SCHEMBL4891783 0.86 BCHE (0.45) ACHEBCHECHRM1SIGMAR1
SCHEMBL4915875 0.85 MCHR1 (0.33) TAAR1MCHR1ACHEBCHEDRD2
SCHEMBL6034236 0.83 HIF1A (0.38) TAAR1MCHR1CNR1KMT2AGAA
Hydrochloric Acid SCHEMBL4895011 0.82 HIF1A (0.38) TAAR1MCHR1KMT2AGAATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060063769-A1 Preventives/remedies for urinary disturbance TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-03-23 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063769-A1 Preventives/remedies for urinary disturbance ACHE, BPHL, CHRM1 TAAR1 634/4885MCHR1 1502/4885ACHE 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.